Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-372-4 | CAS number: 106-20-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
There was no data available for the determination of toxicokinetics, metabolism and distribution. An assessment was done based on physico-chemical properties of the test substance and available data on acute and repeated dose toxicity.
Key value for chemical safety assessment
Additional information
There was no data available for the determination of toxicokinetics, metabolism and distribution.
Assessment of Toxicokinetic Behaviour
Bis(2-ethylhexyl)amine (CAS-No. 106-20-7) is a colorless liquid with a molecular weight of 241.46 g/mol and a vapour pressure of 0.0023 hPa at 20°C. It has a low water solubility of 14 mg/L at 20°C, the log Pow is 7.3 at 25°C and the pH is 7.5. The high logPow indicates that a general accumulation of the test substance is possible.
The substance is described with a purity of generally >/= 99%, with water (</= 0.1%) as further component.
Absorption
Data for absorption can be taken from acute (oral, inhalative and dermal) and chronic toxicity studies.
In an acute oral toxicity study (BASF AG 1967) a LD50 of 1008 mg/kg bw for male and female rats was determined. The female animals appeared to be more sensitive. Main clinical signs observed were irregular/ accelerated respiration, heavy ruffled fur, anogenital region smeared with feces (diarrhea), squatting posture, apathy, red eye and nose crusts. All survivors recovered. At necropsy of the dead animals, dilated stomach, atony and blood smeared snouts were observed. The sacrificed animals showed uneven faded liver, adhesion between liver, stomach, spleen and left kidney; bronchitis or bronchopneumonia with emphysema.
Additionally, a Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test was conducted. The test substance was administered in corn oil as vehicle at dosages of 7.5, 25, and 75 mg/kg body weight/day, and controls received the vehicle only. At 75 mg/kg bw/day, bedding in mouth, accompanied by slight salivation in some isolated animals was noted. Furthermore, there was a slight decrease in mean body weight gain after treatment start in males, which was considered to be not adverse. Hematological and clinical chemistry examinations did not reveal any adverse effects. Increased liver and kidney weights were observed in females at 25 and 75 mg/kg bw/day. However, there were no hints for an impaired function of these organs by clinical chemistry and histopathology. All microscopic findings recorded were within the range of normal background lesions which may be recorded in animals of this strain and age. No effects on reproduction and development were observed at any dose level. The general NOAEL was considered to be 75 mg/kg body weight/day.
The findings reported above may indicate bioavailability of bis(2-ethylhexyl)amine after oral uptake. But the acute study may also represent side effects of the corrosive potential of the test item. Due to the lipophilic nature of the compound, it may be taken up by micellular solubilisation (ECHA guidance document R.7c, 2017).
An acute inhalation toxicity test was performed (BASF AG 1991) with a test substance as aerosol and a LC50 of 0.91 mg/Lfor male and female rats was observed. Main clinical signs were local irritation of the airways and of the eyes. 30 min post application tonic-clonic convulsions, restlessness, pain reflex and intermittent respiration were noted. Also effects on body weight were noted. At necropsy, general congestion and pulmonary hyperemia with edema were observed. Additional data were available from inhalation risk tests (IRT). The inhalation of a saturated vapour-air mixture (0.2 mg/L) for 8 h caused no mortality in male and female rats (strain not specified). Symptoms described included signs of irritation of the mucous membranes and post mortem examination revealed occasional bronchopneumonia (BASF AG 1967; reliability score 2). In a second IRT, groups of six male albino rats (strain unspecified) were exposed to a flowing stream of air substantially saturated with vapours of the test material. No mortality was observed (Smyth et al. 1949; reliability score 2).
In the described inhalation studies, it seems that the main effects were local effects due to the corrosive potential of the test substance. Due to the low vapour pressure of 0.0023 hPa (at 20°C) the exposure to this substance via the inhalation route might be of less importance. However, if inhaled the high logPow value of 7.3 and the low water solubility may favor uptake by micellular solubilisation (ECHA guidance document R.7c, 2017).
A dermal LD50 value of 1.19 mL/kg, equivalent to 958 mg/kg bw, was reported for rabbits, with no further details provided (Union Carbide 1968). According to the ECHA guidance document R.7c, 2017, the dermal absorption of test substances with water solubility between 1-100 mg/L is anticipated to be low to moderate. Additionally, the results of the acute oral and acute inhalative toxicity tests indicated, that local effects caused by the corrosive properties of the test substance which might led to destruction of membrane barriers during the acute dermal toxicity study were more important than toxicity via systemic availability.
Taken together, bis(2-ethylhexyl)amine resulted in mortality after oral, inhalative and dermal exposure. Thus, the substance might be systemic available via these routes of exposure. However, as bis(2-ethylhexyl)amine is also caustic the existing data indicate that corrosion and also irritation of the respiratory tract (local effects) are the primary effects.
All available in vitro studies on genotoxicity, with or without metabolic activation, were negative. Therefore, there is no indication of a strong reactivity of bis(2-ethylhexyl)amine and/ or its metabolites under the chosen test conditions.
Distribution
Because of the high logPow value of 7.3 the substance is likely to reach the intracellular compartment. Further, even though data for the body half-life of the substance is not available, bioaccumulation in adipose tissue under repeated exposure conditions cannot be excluded.
Metabolism
If not excreted unchanged, secondary amines like bis(2-ethylhexyl)amine could be N-dealkylated and also N-oxygenated with oxidative N-dealkylation as predominant process which lead to aldehydes as products (Mayer R.T., 2007; Seto J., 1993; Yamada H., 1997). The aldehyde is further metabolized to the respective carboxylic acid.
Excretion
Due to its molecular weight, as well as its vapour pressure, bis(2-ethylhexyl)amine is expected to be excreted predominantly via the urine (ECHA guidance document R.7c, 2017).Urinary excretion is also assumed for the metabolic end product carboxylic acid.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.